International impact of external reference pricing: should national policy makers care?

3 November 2019 - External reference pricing is widely used to regulate drug prices.  ...

Read more →

Real-time benefit tools for drug prices

25 October 2019 - Concerns over drug prices and medication nonadherence have led to a search for new strategies to lower ...

Read more →

International pricing index ‘accomplishes nothing it sets out to do’

21 October 2019 - Even with all of the political chatter in Washington, D.C., talk about controlling prescription drug prices ...

Read more →

Variation in prescription drug prices by retail pharmacy type: a national cross-sectional study

1 October 2019 - Cash prices for prescription drugs vary widely in the United States. ...

Read more →

New Zealand's access to funded medicines 'well behind the rest of the world'

12 August 2019 - New Zealand has the worst access to funded modern medicines of 20 OECD countries, a report ...

Read more →

Bev takes 14 pills a day. She's far from alone.

15 July 2019 - She is among the more than one-in-three Australians aged over 70 who take five or more different ...

Read more →

CMS’s international pricing model for Medicare Part B drugs: implementation issues

9 July 2019 - For many years, Americans have paid significantly more than the rest of the world for prescription drugs. ...

Read more →

Population adjustment methods for indirect comparisons: A review of NICE Technology Appraisals

13 June 2019 - Indirect comparisons via a common comparator (anchored comparisons) are commonly used in health technology assessment. However, ...

Read more →

Hospital drug prices are up to 7 times greater than Medicare pricing

15 February 2019 - A new study shows something many healthcare patients know all too well: hospitals are charging significant ...

Read more →

What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries.

7 February 2019 - Decisions on the reimbursement of the same cancer drugs are different across European countries, but empirical work ...

Read more →

Comparing PHARMAC's outcomes with those of Australia

7 February 2019 - New Zealand's Prime Minister Jacinda Ahern's claim that is unfair to compare PHARMAC's outcomes with those ...

Read more →

Jacinda Ardern: not fair to compare PHARMAC with Australia's system

5 February 2019 - Jacinda Ardern told The AM Show New Zealand's drug buying agency has "been pointed to as being ...

Read more →

The U.S. should assess the economic value of drugs rather than leave it up to other countries

17 January 2019 - One reason why prescription drugs are often priced lower overseas is that many countries perform detailed ...

Read more →

Comparative assessment of clinical benefit using the ESMO Magnitude of Clinical Benefit Scale version 1.1 and the ASCO Value Framework Net Health Benefit Score

19 December 2018 - To better understand the European Society for Medical Oncology-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) ...

Read more →

Dozens of groups attack Trump plan to peg drug prices to what other countries pay

10 December 2018 - A controversial Trump administration plan to lower drug costs by pegging prices to what are paid ...

Read more →